Lucid Diagnostics Inc.
LUCD
$1.20
-$0.01-0.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.10% | 49.68% | 513.84% | 124.44% | 828.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.10% | 49.68% | 513.84% | 124.44% | 828.57% |
| Cost of Revenue | 47.27% | 3.06% | 4.20% | 23.77% | -11.74% |
| Gross Profit | -133.51% | 39.84% | 54.10% | 26.57% | 74.24% |
| SG&A Expenses | 13.71% | 15.37% | 15.45% | -25.06% | -19.32% |
| Depreciation & Amortization | -64.71% | -79.21% | -79.21% | -54.41% | 24.55% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.84% | 8.02% | 3.62% | -20.12% | -17.19% |
| Operating Income | -7.18% | -5.09% | 3.38% | 24.62% | 23.51% |
| Income Before Tax | -6.57% | 12.93% | 3.30% | 34.68% | 27.46% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.57% | 12.93% | 3.30% | 34.68% | 27.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.57% | 12.93% | 3.30% | 34.68% | 27.46% |
| EBIT | -7.18% | -5.09% | 3.38% | 24.62% | 23.51% |
| EBITDA | -11.35% | -9.29% | -0.11% | 24.91% | 24.62% |
| EPS Basic | 22.71% | 27.64% | 16.10% | -1.44% | 35.94% |
| Normalized Basic EPS | 49.84% | 13.51% | 17.55% | 36.77% | 35.94% |
| EPS Diluted | 22.71% | 27.64% | 16.10% | -1.44% | 35.94% |
| Normalized Diluted EPS | 49.84% | 13.51% | 17.55% | 36.77% | 35.94% |
| Average Basic Shares Outstanding | 37.91% | 20.33% | 15.25% | 9.87% | 13.22% |
| Average Diluted Shares Outstanding | 37.91% | 20.33% | 15.25% | 9.87% | 13.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |